Neuropilin-1 is a host factor for SARS-CoV-2 infection

James L Daly,Boris Simonetti,Katja Klein,Kai-En Chen,Maia Kavanagh Williamson,Carlos Antón-Plágaro,Deborah K Shoemark,Lorena Simón-Gracia,Michael Bauer,Reka Hollandi,Urs F Greber,Peter Horvath,Richard B Sessions,Ari Helenius,Julian A Hiscox,Tambet Teesalu,David A Matthews,Andrew D Davidson,Brett M Collins,Peter J Cullen,Yohei Yamauchi,James L. Daly,Deborah K. Shoemark,Urs F. Greber,Richard B. Sessions,Julian A. Hiscox,David A. Matthews,Andrew D. Davidson,Brett M. Collins,Peter J. Cullen
DOI: https://doi.org/10.1126/science.abd3072
IF: 56.9
2020-11-13
Science
Abstract:Another host factor for SARS-CoV-2 Virus-host interactions determine cellular entry and spreading in tissues. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the earlier SARS-CoV use angiotensin-converting enzyme 2 (ACE2) as a receptor; however, their tissue tropism differs, raising the possibility that additional host factors are involved. The spike protein of SARS-CoV-2 contains a cleavage site for the protease furin that is absent from SARS-CoV (see the Perspective by Kielian). Cantuti-Castelvetri et al. now show that neuropilin-1 (NRP1), which is known to bind furin-cleaved substrates, potentiates SARS-CoV-2 infectivity. NRP1 is abundantly expressed in the respiratory and olfactory epithelium, with highest expression in endothelial and epithelial cells. Daly et al. found that the furin-cleaved S1 fragment of the spike protein binds directly to cell surface NRP1 and blocking this interaction with a small-molecule inhibitor or monoclonal antibodies reduced viral infection in cell culture. Understanding the role of NRP1 in SARS-CoV-2 infection may suggest potential targets for future antiviral therapeutics. Science , this issue p. 856 , p. 861 ; see also p. 765
multidisciplinary sciences
What problem does this paper attempt to address?